While the safety of GLP-1 drugs in people with lupus is still under study, there are several potential benefits that could make them an appealing option for those with coexisting conditions, such as diabetes or obesity
They are also typically less expensive to manufacture, which could lead to lower costs for patients
[DOI] [PubMed] [Google Scholar] 36.Plamboeck A, Veedfald S, Deacon CF, et al
Ideguchi, H
A methylated (methyl.) and an unmethylated (unmethyl.) bisulfite-treated DNA sample were used as controls
The six interactions weve discussed sulfonylureas, insulin, oral contraceptives, digoxin, warfarin, and medications with a narrow therapeutic index each come with specific challenges that demand thoughtful management and close monitoring